跳至主要内容
临床试验/jRCTs051220110
jRCTs051220110招募中不适用

Specified clinical trial for fecal microbiota transplantation and gut microbiota reconstruction in patients with refractory diarrhea

未提供0 个研究点目标入组 10 人开始时间: 2023年6月6日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
10
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 No limit(—)
性别
All

入选标准

  • Study subject:
  • (1) Aged 18 years or older at informed consent.
  • (2) Patient with prolonged diarrhea more than 10 days despite of standard treatment for diarrhea, or who continue to have diarrhea without using antidiarrheal drugs.
  • (3) Patient with dysbiosis in the gut assessed using stool smear.
  • (4) Patient with written consent to participate in this study from the patient or his/her surrogate.
  • (1) Aged 18-70 years (If possible, relatives of the study subject).
  • (2) Patient without dysbiosis in the gut assessed using stool smear.
  • (3) If the study subject has a food allergy, person who is possible not to consume the food for at least 5 days before stool collection.
  • (4) Person with written consent from the person regarding the implementation of interview and various tests specified in this study and the provision of stool.

排除标准

  • Study subject:
  • (1) Patient with shock (blood lactate level 18 mg/dL or higher) or who using catecholamines.
  • (2) Patient with severe immunodeficiency <500 / microL of neutrophils.
  • (3) Patient who cannot expect a prognosis of 3 months or more even if diarrhea have subsided.
  • (4) Patient who are judged by the investigator to be inappropriate as research subjects for other reasons.
  • (1) Person suspected to have infection by interviewing and screening for blood and stool tests, or who have disease that should be excluded.
  • Excluded diseases: inflammatory bowel disease, irritable bowel syndrome, chronic diarrhea, severe constipation, malignant tumor under treatment, autoimmune disease, severe obesity, Parkinson's disease, autism, depression, Creutzfeldt-Jakob's disease.
  • For cytomegalovirus and EB virus, when the study subject is not infected, if the donor's screening test result is positive, it is non-eligible.
  • (2) Parson who are judged by the investigator to be inappropriate as doner for other reasons

结局指标

主要结局

-

Adverse events

次要结局

  • Changes in stool shape
  • Changes in gut microbiota

研究者

发起方
未提供

相似试验